Ohio State University at AAPS 2026 PharmSci 360
Oct 25–28, 2026 New Orleans, LA ~4k attendees Website
Ohio State University brings 2 presentations to AAPS 2026 PharmSci 360 in New Orleans. Ohio State University's program spans lung drug delivery and cancer drug resistance. Its work covers rapamycin liposomes delivered to the lung that calm inflammation in a model of acute respiratory distress, and ways around acquired etoposide resistance in leukemia cells.
| Organization | AAPS 2026 PharmSci 360 Attendance |
|---|---|
Ohio State University Columbus, OH | |
Poster Tue Oct 27 2:30pm–3:30pm Pulmonary Delivery of Rapamycin-Loaded Liposomal Nanoparticles Attenuates Inflammation Through mTORC1 Inhibition in an LPS-Induced ARDS Model Poster Wed Oct 28 11:30am–12:30pm Circumvention of Acquired Resistance to the Anticancer Agent Etoposide in Human Leukemia K562 Cells: Role of the Cleavage and Polyadenylation Factor PCF11 |
Instantly find 20 buyers from Ohio State University
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction